Skip to content
The Kids Research Institute Australia logo
Donate

No results yet

Search

Showing results for "1"

News & Events

Meet Perth's final ENDIA participant

Australia’s biggest study into the causes of type 1 diabetes reached a significant milestone when its last Perth-based participant was born recently.

News & Events

Jazmyn's journey begins

Ten-year-old Jazmyn Kalin’s diabetes journey may have only just begun but she is taking it all in her stride, administering her own insulin needles and even learning about carbs.

News & Events

Testing how much protein is needed to prevent overnight hypos which can happen after exercise

We're testing how much protein is needed to prevent overnight hypos which can happen after exercise

Research

Association between male genital anomalies and adult male reproductive disorders: a population-based data linkage study spanning more than 40 years

We provide new evidence to support current guidelines for orchidopexy before age 18 months to decrease the risk of future testicular cancer and infertility

Resources

Find newsletters, guidelines, publications and videos in the one spot.

Research

Immunogenicity and Safety of a Quadrivalent Meningococcal ACWY-tetanus Toxoid Conjugate Vaccine 6 Years After MenC Priming as Toddlers

One dose of MenACWY-TT boosts protection against MenC in primed children, is safe and extends protection against MenA, MenW and MenY

News & Events

Healthcare Transition Support

HEALTHCARE TRANSITION STUDY Co-designing transition support: Phase 1 For young people with type 1 diabetes (T1D), growing up means moving from child

Research

A phase 3 study of safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, followed by 23-valent pneumococcal polysaccharide vaccine, in children with HIV

To evaluate the safety and immunogenicity of V114 [15-valent pneumococcal conjugate vaccine (PCV) containing serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9 V, 14, 18C, 19A, 19F, 22F, 23F, 33F], followed by 23-valent pneumococcal polysaccharide vaccine (PPSV23) 8 weeks later, in children with HIV.

News & Events

Protein, exercise and hypo study

For this study, we want to see how much protein is necessary to prevent overnight hypos without causing high blood glucose levels.